bpc-157 clinical evidence randomized trial humans BPC-157: What the Science Actually Says Wellness clinics promote the use
Description
But it can lead to serious complications
General statements about broad compatibility of any diluent with investigational peptides are not supported by authoritative evidence and should not be relied upon
Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: Role of the nitric oxide-system
Hauser RA, et al
